Through the meta-analyses of gene-expression difference in tumor vs. normal, in ADC vs. SQCC, and in mutants vs. WT for EGFR or KRAS as well as the meta-analyses of survival association and gene–gene correlation, we present multiple lines of evidence generated from our lung cancer database to strengthen the existing findings. Here, KRAS is linked to lung carcinoma.